Stalfort John A Iii - Net Worth and Insider Trading
Stalfort John A Iii Net Worth
The estimated net worth of Stalfort John A Iii is at least $27 Million dollars as of 2024-04-27. Stalfort John A Iii is the Director of Dova Pharmaceuticals Inc and owns about 635,665 shares of Dova Pharmaceuticals Inc (DOVA) stock worth over $18 Million. Stalfort John A Iii is the Director of Taysha Gene Therapies Inc and owns about 1,933,671 shares of Taysha Gene Therapies Inc (TSHA) stock worth over $5 Million. Stalfort John A Iii is also the Director of Verrica Pharmaceuticals Inc and owns about 462,110 shares of Verrica Pharmaceuticals Inc (VRCA) stock worth over $3 Million. Besides these, Stalfort John A Iii also holds Acumen Pharmaceuticals Inc (ABOS) . Details can be seen in Stalfort John A Iii's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Stalfort John A Iii has not made any transactions after 2023-08-16 and currently still holds the listed stock(s).
Transaction Summary of Stalfort John A Iii
Stalfort John A Iii Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stalfort John A Iii owns 4 companies in total, including Verrica Pharmaceuticals Inc (VRCA) , Dova Pharmaceuticals Inc (DOVA) , and Acumen Pharmaceuticals Inc (ABOS) among others .
Click here to see the complete history of Stalfort John A Iii’s form 4 insider trades.
Insider Ownership Summary of Stalfort John A Iii
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VRCA | Verrica Pharmaceuticals Inc | 2020-08-14 | director |
| DOVA | Dova Pharmaceuticals Inc | 2019-11-12 | director |
| ABOS | Acumen Pharmaceuticals Inc | 2021-07-06 | director |
| TSHA | Taysha Gene Therapies Inc | 2023-08-16 | director |
Stalfort John A Iii Latest Holdings Summary
Stalfort John A Iii currently owns a total of 4 stocks. Among these stocks, Stalfort John A Iii owns 635,665 shares of Dova Pharmaceuticals Inc (DOVA) as of December 20, 2018, with a value of $18 Million and a weighting of 67.05%. Stalfort John A Iii owns 1,933,671 shares of Taysha Gene Therapies Inc (TSHA) as of August 16, 2023, with a value of $5 Million and a weighting of 17.38%. Stalfort John A Iii also owns 462,110 shares of Verrica Pharmaceuticals Inc (VRCA) as of August 14, 2020, with a value of $3 Million and a weighting of 11.94%. The other 1 stocks Acumen Pharmaceuticals Inc (ABOS) have a combined weighting of 3.62% among all his current holdings.
Latest Holdings of Stalfort John A Iii
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DOVA | Dova Pharmaceuticals Inc | 2018-12-20 | 635,665 | 28.04 | 17,824,047 |
| TSHA | Taysha Gene Therapies Inc | 2023-08-16 | 1,933,671 | 2.39 | 4,621,474 |
| VRCA | Verrica Pharmaceuticals Inc | 2020-08-14 | 462,110 | 6.87 | 3,174,696 |
| ABOS | Acumen Pharmaceuticals Inc | 2021-07-06 | 303,919 | 3.17 | 963,423 |
Holding Weightings of Stalfort John A Iii
Stalfort John A Iii Form 4 Trading Tracker
According to the SEC Form 4 filings, Stalfort John A Iii has made a total of 0 transactions in Dova Pharmaceuticals Inc (DOVA) over the past 5 years. The most-recent trade in Dova Pharmaceuticals Inc is the acquisition of 31,000 shares on December 20, 2018, which cost Stalfort John A Iii around $194,060.
According to the SEC Form 4 filings, Stalfort John A Iii has made a total of 1 transactions in Taysha Gene Therapies Inc (TSHA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Taysha Gene Therapies Inc is the acquisition of 777,778 shares on August 16, 2023, which cost Stalfort John A Iii around $700,000.
According to the SEC Form 4 filings, Stalfort John A Iii has made a total of 1 transactions in Verrica Pharmaceuticals Inc (VRCA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Verrica Pharmaceuticals Inc is the acquisition of 31,250 shares on August 14, 2020, which cost Stalfort John A Iii around $200,312.
More details on Stalfort John A Iii's insider transactions can be found in the Insider Trading History of Stalfort John A Iii table.Insider Trading History of Stalfort John A Iii
- 1
Stalfort John A Iii Trading Performance
GuruFocus tracks the stock performance after each of Stalfort John A Iii's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stalfort John A Iii is 8.88%. GuruFocus also compares Stalfort John A Iii's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stalfort John A Iii within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Stalfort John A Iii's insider trading performs compared to the benchmark.
Performance of Stalfort John A Iii
Average Return
6.74%
Outperforming Transactions
67%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 28.06 | 8.88 | 17.85 | 6.74 | -22.79 | -7.98 |
| Relative Return to S&P 500(%) | 24.48 | 1.48 | 2.76 | -9.24 | -34.65 | -24.17 |
Stalfort John A Iii Ownership Network
Ownership Network List of Stalfort John A Iii
Ownership Network Relation of Stalfort John A Iii
Stalfort John A Iii Owned Company Details
What does Verrica Pharmaceuticals Inc do?
Who are the key executives at Verrica Pharmaceuticals Inc?
Stalfort John A Iii is the director of Verrica Pharmaceuticals Inc. Other key executives at Verrica Pharmaceuticals Inc include 10 percent owner Perceptive Life Sciences Master Fund Ltd , director & President and CEO Ted White , and Chief Commercial Officer Joe Bonaccorso .
Verrica Pharmaceuticals Inc (VRCA) Insider Trades Summary
Over the past 18 months, Stalfort John A Iii made no insider transaction in Verrica Pharmaceuticals Inc (VRCA). Other recent insider transactions involving Verrica Pharmaceuticals Inc (VRCA) include a net purchase of 2,060,199 shares made by Perceptive Life Sciences Master Fund Ltd , a net sale of 84,376 shares made by Ted White , and a net sale of 71,108 shares made by Joe Bonaccorso .
In summary, during the past 3 months, insiders sold 0 shares of Verrica Pharmaceuticals Inc (VRCA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 288,608 shares of Verrica Pharmaceuticals Inc (VRCA) were sold and 2,260,199 shares were bought by its insiders, resulting in a net purchase of 1,971,591 shares.
Verrica Pharmaceuticals Inc (VRCA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Verrica Pharmaceuticals Inc Insider Transactions
Stalfort John A Iii Mailing Address
Above is the net worth, insider trading, and ownership report for Stalfort John A Iii. You might contact Stalfort John A Iii via mailing address: C/o Acumen Pharmaceuticals, Inc., 427 Park Street, Charlottesville Va 22902.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
